Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Wei, Yongkun

Class:IdPerson:6789542
_displayNameWei, Yongkun
_timestamp2015-08-03 15:31:46
created[InstanceEdit:6789598] Jupe, Steve, 2015-08-03
firstnameYongkun
initialY
surnameWei
(author)[LiteratureReference:6789638] Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression
[LiteratureReference:6789977] Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
[LiteratureReference:6807205] Deubiquitylation and stabilization of PTEN by USP13
[LiteratureReference:8857527] The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer
[LiteratureReference:9931284] IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
[LiteratureReference:9931412] Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function
[LiteratureReference:9934581] MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation
[LiteratureReference:9935388] Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
[LiteratureReference:9943677] GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers
[Change default viewing format]
No pathways have been reviewed or authored by Wei, Yongkun (6789542)